EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs

Abeer A I Hassanin iD, Kenneth S Ramos iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910674 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Abeer A I Hassanin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic and Precision Medicine, Texas Medical Center, Texas A&M Institute of Biosciences and Technology, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, MicroRNAs, Exosomes, Lung Neoplasms. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIH, Governor’s University Research Initiative (GURI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several microRNAs (miRNAs), including miR-221-5p, Let-7b-5p, miR-21-5p, miR-9-5p, miR-126-3p, and miR-222-3p, were recently found to be enriched in circulating exosomes of patients with non-small cell lung cancers (NSCLCs). These miRNAs distinguished cancer cases from controls with high precision and were predicted to modulate the expression of genes within the oncogenic LINE-1 regulatory network. To test this hypothesis, plasma exosomes from controls, early, and late-stage NSCLC patients were co-cultured with non-tumorigenic lung epithelial cells for 72 h and processed for measurements of gene expression. Exosomes from late-stage NSCLC patients markedly increased the mRNA levels of LINE-1 ORF1 and ORF2, as well as the levels of target miRNAs in naïve recipient cells compared to saline or control exosomes. Late-stage exosomes also modulated the expression of oncogenic targets within the LINE-1 regulatory network, namely, ICAM1, AGL, RGS3, RGS13, VCAM1, and TGFβ1. In sharp contrast, exosomes from controls or early-stage NSCLC patients inhibited LINE-1 expression, along with many of the genetic targets within the LINE-1 regulatory network. Thus, late-stage NSCLC exosomes activate LINE-1 and miRNA-regulated oncogenic signaling in non-tumorigenic, recipient lung bronchial epithelial cells. These findings raise important questions regarding lung cancer progression and metastasis and open the door for the exploration of new therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungMicroRNAsExosomesLung NeoplasmsGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMaleFemaleMiddle AgedCell Line, TumorAged

Stichwörter der Autor:innen

LINE-1microRNA profilesnon-small cell lung canceroncogenic signalingplasma exosomes

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Center for Genomic and Precision Medicine, Texas Medical Center, Texas A&M Institute of Biosciences and Technology, Houston, TX 77030, USA.
  • Department of Animal Wealth Development, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt.

ORCID-Profile: Abeer A I Hassanin, Kenneth S Ramos

Förderung

  • NIEHS NIH HHS
  • NIH
  • Governor’s University Research Initiative (GURI)

Zitieren

APA

Hassanin, A. A. I., & Ramos, K. S. (2024). Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910674

Vancouver

Hassanin AAI, Ramos KS. Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910674

BibTeX
@article{Hassanin2024,
  author = {Hassanin, Abeer A I and Ramos, Kenneth S},
  title = {Modulation of the Oncogenic LINE-1 Regulatory Network in Non-Small Cell Lung Cancer by Exosomal miRNAs},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910674}
}
Kostenlos starten →